Shriram General Insurance Exceeds Industry Performance Again in Q4: Reports 21 % Growth in Premium Income

▴ Mr. Anil Aggarwal, MD & CEO of Shriram General Insurance Company
Shriram General Insurance Company (SGI) reported a strong Q4FY26 performance, with Gross Direct Premium (GDP) rising 21% YoY to ₹1,332 Cr from ₹1,099 Cr, significantly ahead of the industry growth of 11%.
National, May 13, 2026: Shriram General Insurance Company (SGI) reported a strong Q4FY26 performance, with Gross Direct Premium (GDP) rising 21% YoY to ₹1,332 Cr from ₹1,099 Cr, significantly ahead of the industry growth of 11%. The growth was primarily driven by the company’s motor insurance portfolio.  For fiscal FY26 SGI’s GDP increased 24% to ₹4,636 crore from ₹3,753 Cr YoY –clocking 2.54 X the industry growth of 9% -reinforcing its position as one of the fastest-growing private general insurers in the country.
SGI’s Investment income rose by 22% in Q4 FY26 against 13% in Q4FY25.
SGI’s focus on profitable growth translated into a 28 % YoY increase in net profit, rising to ₹167Cr in Q4 FY26 from ₹130 Cr in the same period last year. For FY26 the net profit rose to Rs.601Cr from Rs.515 Cr - a 17 % increase from the previous year.
The Board approved final dividend payout of 53% taking the overall dividend payout for the fiscal@162%. For the previous year, SGI declared a total dividend of 140%.
The company continued to maintain a strong balance sheet, with a solvency ratio of 2.95 as of March 2026, above the regulatory requirement of 1.50.
Agent Network Expansion Drives Growth: SGI’s prudent phygital model remains a key enabler of its consistent growth. The company onboarded 19221 new financial advisors during FY26, an 18% increase over the previous year. The total advisor strength currently is 105675.
Branch network expanded to 289 from 279 a year ago, further strengthening its physical presence across geographies.
Active policies grew to 69 lakhs as of March 2026, compared to 65 lakhs in the previous year, reflecting deeper customer reach and sustained business momentum.
Segment wise GDP (in Rs. Cr)  
Particulars
Q4FY26
Q4FY25
Growth %
In FY26
In FY25
Growth %
Motor
1252.66
1031.17
21.48%
4293.01
3478.06
23.43%
Personal Accident
33.74
27.95
20.71%
139.95
119.49
17.13%
Fire
12.78
17.21
-25.76%
92.03
87.11
5.65%
Engineering
7.96
6.76
17.78%
29.06
24.10
20.59%
Health Insurance
9.89
1.58
524.82%
17.50
3.68
375.44%
Others Miscellaneous
14.63
14.43
1.42%
63.95
40.94
56.21%
Total
1332
1099
21.16%
4635.51
3753.38
23.50%
  
Mr. Anil Aggarwal, MD & CEO, Shriram General Insurance Company, said:
“Our FY26 performance reflects the strength of our business model and our focus on profitable and sustainable growth. Despite a competitive market environment, we outperformed the industry growth for the fourth consecutive year. Our motor portfolio remained key growth driver for the last quarter supported by disciplined underwriting, deeper distribution reach, and stronger claims servicing capabilities.”
New Product of the quarter:
Shri Health Suraksha 2.0: an enhanced indemnity-based health insurance plan offering all-inclusive protection with no room rent capping, unlimited restoration of sum insured, zero co-payment, and coverage for ambulance, air ambulance, consumables, and AYUSH treatments.
SGI’s next phase of Growth:
  • Distribution scale-up: SGI plans to expand its Financial Advisor network to 2 lakhs by FY 2029–30.
  • Growth targets: The company expects to close the next fiscal with ₹6000 Cr in GDP and reach ₹10,000 Cr by 2030.
  • Product diversification: SGI is exploring opportunities in parametric insurance and surety bond insurance
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

CARE Hospitals to Offer Free Vascular Health Check on National Vascular DayAugust 05, 2026
Breastfeeding Myths That New Mothers Should Stop BelievingAugust 05, 2026
Why Modern Lifestyle Causes Chronic InflammationAugust 05, 2026
Endometriosis Awareness: Understanding the Silent Condition Affecting Millions of Indian WomenAugust 05, 2026
A Complete Guide to Pregnancy Health Tips for Indian Women: Nutrition, Wellness, and What Every Expectant Mother Should KnowAugust 05, 2026
Metropolis Healthcare reports strong Q1FY27 performance, with revenue up 17% to ₹450 crore and EBITDA up 27% YoYAugust 04, 2026
India's Silent Liver Health Crisis: New Data Points to Urgent Need for Screening and PreventionAugust 04, 2026
Eureka Forbes Launches 'Ghar Ka New Favourite' Campaign showcasing Forbes SmartClean Robotic Vacuum Cleaner with Shraddha KapoorAugust 04, 2026
Why Preventive Healthcare for Children Is One of the Most Important Investments India Can MakeAugust 04, 2026
The Role of Pathology in Healthcare: From Diagnosis to Disease PreventionAugust 04, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 04, 2026
Comprehensive Evaluation of Syncope: Cardiac vs. Neurological Origin WorkupsAugust 04, 2026
Common Medical Terms Explained: A Plain-Language Guide for Indian Patients and Healthcare SeekersAugust 03, 2026
Why Radiology Is the Backbone of Modern Medical Diagnosis and TreatmentAugust 03, 2026
Managing Urban Stress: Science-Backed Strategies for Mental Resilience in 2026 August 01, 2026
Managing Chronic Inflammation: The Role of Anti-Inflammatory Indian SuperfoodsAugust 01, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 01, 2026
Early Markers of Glaucoma: Structural vs. Functional Ophthalmic Diagnostic ProtocolsAugust 01, 2026
Managing Complex Diabetic Foot Ulcers: Multidisciplinary Wound Care, Offloading, and RevascularizationAugust 01, 2026
The Future of Preventive Medicine: How India Is Moving From Cure to PreventionAugust 01, 2026